Emerging Frontiers in Microbiome Engineering
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 40 (10) , 952-973
Abstract
No abstract availableKeywords
Funding Information
- ALS Association (18-IIA-403)
- Army Research Office (W911NF-17-2-0077)
- United States-Israel Binational Science Foundation (2017189)
- Singapore-MIT Alliance for Research and Technology Centre
- Leona M. and Harry B. Helmsley Charitable Trust
- Breast Cancer Alliance
- U.S. Army Medical Command
- Pew Charitable Trusts (00030623)
- Human Frontier Science Program (LT000595/2017-L)
- Medical Research and Materiel Command (W81XWH-17-1-0159)
- Medical Research and Materiel Command (W81XWH-16-1-0565)
- Medical Research and Materiel Command (W81XWH-18-1-0513)
- American Heart Association (229460)
- National Science Foundation (CCF-1521925)
- National Science Foundation (DMR-1419807)
- Defense Threat Reduction Agency (E2045481)
- George Mason University (HDTRA1-14-1-0007)
- George Mason University (HDTRA1-15-1-0050)
- National Institutes of Health (229825)
- Massachusetts General Hospital (4-R33-AI121669-04)
- Human Frontier Science Program
- University of Pennsylvania
- Defense Advanced Research Projects Agency (HR0011-15-C-0084)
- Defense Advanced Research Projects Agency (152304.5106735.0006)
- Space and Naval Warfare Systems Command (N66001-13-C-4025)
This publication has 155 references indexed in Scilit:
- Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut MicrobiomeCell, 2017
- Mining the Human Gut Microbiota for Immunomodulatory OrganismsCell, 2017
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s DiseaseCell, 2016
- Microbiome therapeutics — Advances and challengesAdvanced Drug Delivery Reviews, 2016
- Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome SignalingCell, 2015
- Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental DisordersCell, 2013
- Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-β1 under the control of dietary xylanInflammatory Bowel Diseases, 2011
- Nisin‐inducible secretion of a biologically active single‐chain insulin analog by Lactococcus lactis NZ9000Biotechnology and Bioengineering, 2011
- Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota AlterationsCell, 2010
- Probiotic Lactobacillus casei Expressing Human Lactoferrin Elevates Antibacterial Activity in the Gastrointestinal TractBioMetals, 2010